BioHarvest Sciences Inc. (BHST) Q4 2024 Earnings
BHST·Reported March 31, 2025·After market close
BioHarvest Sciences Inc. reported Q4 2024 revenue of $7.3M, beat analyst consensus of $7.2M by $40.0K. Diluted EPS came in at $-0.17, missed the $-0.12 consensus by $0.05.
Revenue
$7.3Mbeat by $40.0K
Consensus: $7.2MDiluted EPS
$-0.17missed by $0.05
Consensus: $-0.12
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about BioHarvest Sciences Inc.'s Q4 2024 earnings report.
BioHarvest Sciences Inc. (BHST) reported Q4 2024 earnings on March 31, 2025 after market close.
BioHarvest Sciences Inc. reported revenue of $7.3M and diluted EPS of $-0.17 for Q4 2024.
Revenue beat the consensus estimate of $7.2M by $40.0K. EPS missed the consensus estimate of $-0.12 by $0.05.